We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Enzychem

News List

Enzychem and Cadila collaborate to produce Covid-19 vaccine in Korea Pharmaceutical-Technology
November 30, 2021
Enzychem Lifesciences and Cadila Healthcare, a Zydus Group unit, have signed an agreement to manufacture the first-ever Covid-19 plasmid deoxyribonucleic acid (DNA) vaccine, ZyCoV-D.
FDA accepts Enzychem’s IND for trial of Covid-19 treatment candidate pharmaceutical-business-review
August 19, 2020
The US Food and Drug Administration (FDA) has accepted Enzychem Lifescience’s investigational new drug application (IND) to assess its EC-18 therapeutic candidate for the prevention of acute respiratory disease syndrome (ARDS) due to Covid-19 pneumonia.
Enzychem Initiates EC-18 Study to Prevent ARDS due to Coronavirus Pneumonia americanpharmaceuticalreview
May 19, 2020
Enzychem Lifesciences announced the Ministry of Food and Drug Safety (MFDS, formerly the Korea Food and Drug Administration), has accepted its Investigational New Drug (IND) application to initiate a Phase 2 study for its lead therapeutic candidate.